Background: Breast cancer is the most common invasive cancer in female worldwide. Indole scaffold represents an important class of therapeutic agents in medicinal chemistry. Many indole derivatives are reported as potent anticancer agents. This study aims to design, and synthesize anti-breast cancer potential of new bisindole derivatives.
INTRODUCTION
Cancer is a multifactor disease with superfluous and robust biological network [1] . It is the family of disease, which despite five decades of intense research still affects 1 in 3 people during the course of their live. Breast cancer is the most common invasive cancer in female worldwide. It accounts for 16% of all female cancers and 22.9% of invasive cancers in women. 18 .2% of all cancer deaths worldwide including both in males and females are from breast cancer. Breast cancer rates are much higher in developed nations compared to developing ones [2] .
Various kinds of treatments are available for breast cancer, such as chemotherapy, radiotherapy and hormone therapy [3] . Recent treatment strategies for cancer have limited efficacy. It may require treatment with compounds that could significant anticancer activity [19, 20] . Recently, MartelFrachet and coworkers reported mono-and bis-indolyl chalcones as potent cytotoxic agents against bladder carcinoma [21] . Lawrence et al. have reported a series of -substituted chalcones possess promising antiproliferative activity against different cancer cell lines [22] . Tarleton et al. reported (z)-2-(3,4-dichlorophenyl)-3-(4-nitrophenyl)acrylonitrile shows significant cytotoxicity against human breast cancer cell line, MCF-7 (GI 50 = 0.127 ± 0.043 M) [23] . More recently, -cyano substituted indolyl chalcones have been found to possess potent anticancer potential [24] .
Based upon these observations and in continuation of our ongoing research programme on the development of novel anticancer agents [25] [26] [27] [28] [29] , herein we synthesized a series of -cyano substituted 1,3-bisindolyl-2-propen-1-one derivatives as potent anti-breast cancer agents.
EXPERIMENTAL

Materials and Methods
IR spectra were recorded on FT-IR Nicolet iS 10 spectrophotometer in KBr pellet and 1 H NMR spectra were recorded on a Bruker 400 MHz spectrometer in CDCl 3 using tetramethylsilane as internal standard and chemical shifts are reported in units and the coupling constants (J) are reported in Hertz. Mass spectra obtained with a Shimadzu LCMS-2010EV. TLC performed on aluminum-backed silica plate with visualization by UV-light and column chromatography using silica gel (mesh size 100-200).
General Procedure for the Preparation of -cyano substituted 1,3-bisindolyl-2-propen-1-one derivatives (5a-t)
3-Cyanoacetylindole (0.1 mole) was dissolved in ethyl alcohol (15 ml) . The appropriate indole-3-carboxaldehyde (0.1 mole) was added, followed by the addition of a solution of piperidine (0.3 mole). The resulting mixture was reflux for 12 hours. After completion of reaction (as indicated by TLC), the mixture was allowed to cool at room temperature, then diluted with water (270 ml) and acidified with dilute HCl solution. The precipitate was filtered off, recrystallized from ethyl alcohol to obtain the title compounds in pure form. Indol-3-yl)-2-(1H-indole-3-carbonyl) 18. 2-(5-methoxy-1H-indole-3-carbonyl)-3-(2-methyl-1H-indol-3-yl) 
(E)3-(1H-
(E)2-(1H-indole-3-carbonyl)-3-(5-methoxy-1H-indol-3-yl)acrylonitrile (5d)
(E)3-(5-bromo-1H-indol-3-yl)-2-(2-methyl-1H-indole-3-carbonyl)acrylonitrile (5h):
(E)(3-(5-methoxy-1H-indol-3-yl)-2-(2-methyl-1H-indole-3-carbonyl)acrylonitrile (5i)
(E)2-(2-methyl-1H-indole-3-carbonyl)-3-(5-nitro-1H-indol-3-yl)acrylonitrile (5j)
(E)2-(5-bromo-1H-indole-3-carbonyl)-3-(1H-indol-3-yl)acrylonitrile (5k)
(E)2-(5-bromo-1H-indole-3-carbonyl)-3-(2-methyl-1H-indol-3-yl)acrylonitrile (5l)
2-(5-bromo-1H-indole-3-carbonyl)-3-(5-methoxy-1H-indol-3-yl)acrylonitrile (5n)
H 4 ),7.56 (d, J = 7.56 Hz, Indole 2 -H 7 ), 7.49 (d, J = 8.4 Hz, 1H
3-(5-bromo-1H-indol-3-yl)-2-(5-methoxy-1H-indole-3-carbonyl)acrylonitrile (5r)
3-(5-methoxy-1H-indol-3-yl)-2-(5-methoxy-1H-indole-3-carbonyl)acrylonitrile (5s)
2-(5-methoxy-1H-indole-3-carbonyl)-3-(5-nitro-1H-indol-3-yl)acrylonitrile (5t)
Procedure of the SRB-Assay
Tumor cells (human breast cancer cell line MCF-7) were grown in tissue culture flasks in growth medium (RPMI-1640 with 2 mM glutamine, pH 7.4, 10% fetal calf serum, 100 mg/ml streptomycin, and 100 units/ml penicillin) at 37 o C under the atmosphere of 5% CO 2 and 95% relative humidity employing a CO 2 incubator. The cells at subconfluent stage were harvested from the flask by treatment with trypsin (0.05% trypsin in PBS containing 0.02% EDTA) and placed in growth medium. The cells with more than 97% viability (trypan blue exclusion) used for cytotoxicity studies. An aliquot of 100 ml of cells transferred to a well of 96-well tissue culture plate. The cells were allowed to grow for one day at 37 o C in a CO 2 incubator as mentioned above. The test materials at different concentrations then added to the wells and cells were further allowed to grow for another 48 h. Suitable blanks and positive controls were also included. Each test performed in triplicate. The cell growth stopped by gently layering of 50 ml of 50% trichloroacetic acid. The plates incubated at 4 o C for an hour to fix the cells attached to the bottom of the wells. Liquids of all the wells were gently pipette out and discarded. The plates were washed five times with doubly distilled water to remove TCA, growth medium, etc, and were air-dried. 100 ml of SRB solution (0.4% in 1% acetic acid) added to each well and the plates incubated at ambient temperature for half an hour. The unbound SRB was quickly removed by washing the wells five times with 1% acetic acid. Plates were air-dried, tris-buffer (100 ml of 0.01 M, pH 10.4) added to all the wells and plates gently stirred for 5 min on a mechanical stirrer. The optical density measured on ELISA reader at 540 nm. The cell growth in the absence of any test material considered 100% and in turn, growth inhibition was calculated. Percent growth calculated on a plate-by-plate basis for test wells relative to control wells. Percent growth expressed as the ratio of average absorbance of the test well to the average absorbance of the control wells 100. Using the six absorbance measurements (time zero, control growth [C] and test growth in the presence of drug at the four concentration levels [Ti]), the percentage growth calculated at each of the extracts and standard drug concentration levels. Percentage growth inhibition was calculated as [Ti/C] 100%.
Molecular Modeling
All the molecules in the resent study were drawn in the molecule builder in V life MDS 4.4.The drawn 2D structures were converted in the 3D structures keeping native geometry intact. The 3D structures were energy minimized using MMFF force field keeping gradient 0.0001kcal/mol. Crystal structures of Proviral insertion in murine (Pim-1), 2obj were downloaded from the free protein database www.rcsb.org. Protein structure is refined using V life MDS4.4 via addition of native hydrogen and removal of the water molecule. The refined protein structure was further utilized for the docking studies.
ADME Predictions
Topological polar surface area, total number of rotatable bonds, number of hydrogen bond donor and acceptor; Molecular weight and log p were determined using V life MDS 4.4 and molinspiration online property calculation server [30] . Absorption was calculated using formula %ABS = 109 -(0.345 x TPSA) [31] .
RESULTS AND DISCUSSION
Chemistry
Synthetic pathway for 1,3-bisindolyl-2-propen-1-one derivatives (5a-t) depicted in Scheme 1. The starting compounds for the synthesis of title compounds, namely 3-cyanoacetyl indoles 4a-d synthesized in good yields by reacting substituted indoles 3 with cyanoacetic acid in the presence of acetic anhydride [32] . On the other hand, indole-3-carboxaldehydes 2 obtained by the reaction of indoles 1 with phosphorus oxychloride in presence of dimethylformamide in good yields [33] . The title compounds, -cyano substituted 1,3-bisindolyl-2-propen-1-one derivatives 5a-t were prepared by the Knoevenagel condensation of 3-cyanocatyl indoles 4 with substituted indole-3-carboxaldehydes 2 in the presence of piperidine in ethanol [34] . The structures of synthesized compounds were confirmed by IR, 1 H NMR, 13 C NMR and HRMS spectral data.
Anti-Breast Cancer Activity
All the synthesized -cyano substituted 1,3-bisindolyl-2-propen-1-one derivatives (5a-t) were evaluated for their in vitro cytotoxic potencies in human breast cancer cell line MCF-7 by employing the sulforhodamine B (SRB) assay method [35] . Adriamycin is one of the most effective anticancer agents used as a reference drug. Three parameters were determined during the screening process such as GI 50 , TGI and LC 50 and the results summarized in Table 1 .
The GI 50 values (growth inhibitory activity) refer to the drug concentration that produces a 50% reduction of cellular growth compared with the untreated control cells. The TGI (cytostatic activity) and LC 50 (cytotoxic activity) values refer to the drug concentration required for total growth inhibition and killing 50% of the cells, respectively. GI 50 values used to classify a compound's activity, which are as follows: inactive, >100 M; moderate, between >10 and <100 M; and active, <10 M.
It is worthy to note that most of the compounds were significantly cytotoxic against MCF-7 compared to the standard drug tested, i.e. adriamycin, with the concentration of the drug that produced 50% inhibition of cell growth (GI 50 ). In general, compounds 5g, 5b and 5q exhibited potent activity (GI 50 = <0.1 M) against the MCF-7 cell line which was Compounds 5h and 5i also exhibited good activity (GI 50 = 12.2 and 13 M respectively) against MCF-7 cell line. On the other hand, compounds 5f, 5l, 5d and 5e showed moderate activity (GI 50 = 21.8 -37.5 M) against MCF-7 cell line. The activities of the other compounds were moderate to weak.
A comparison of the TGI concentrations of the compounds with adriamycin was also done. Most of the compounds were inactive and a few exhibited weak activity against the MCF-7 cell line. Compounds 5g (TGI = 39.3 M), 5i (TGI = 60.5 M), 5h (TGI = 72.2 M), 5f (TGI = 74.6 M), 5e (TGI = 88.9 M), 5d (TGI = 88.9) and 5n (TGI = 97.5 M) exhibited weak activity against MCF-7 cell line. All the other compounds were inactive (TGI >100 GM) as compared to standard drug adriamycin.
The LC 50 concentrations of the compounds were compared to that of adriamycin to get an indication of the cytotoxic effects of these compounds against the MCF-7 cell line. The compounds were inactive (LC 50 = >100 M) like adriamycin (LC 50 = 97.1 M) against the MCF-7 cell line.
Structure activity relationship (SAR) study revealed that the presence of methyl group at 2-position of indole is essential for activity. Compound 5g having methyl substituent at 2-position of both the indole rings exhibited potent activity (GI 50 = <0.1 M, TGI = 39.3 M) against MCF-7 cell line. The introduction of polar groups like methoxy, bromo, nitro at 5-position of ring B increase in activity was observed, whereas, decrease in activity was observed on ring A.
Molecular Docking Study
Proviral insertion in murine (Pim-1), it is proto-oncogene which encodes for serine/threonine kinase, which is over expressed in a number of malignancies and solid cancers. Expression of Pim-1 regulated via multiple biomolecules at different levels. Recently, it has been observed that deregulation of the Pim-1 results in the interference in the cell cycle and apoptosis, this will result in to the promotion of malignant transformation of the number of tumors. Thus, inhibition of Pim-1 regulation may result in important biological target for the development of molecular targeting therapies and drug developments against Pim-1-associated cancers. Accordingly, the active compounds 5g, 5b and 5q were docked into the binding site of Pim-1. Hydrophobic, Hbonding as well as Van der Waals (VdW) interactions are involved in binding of most active compounds 5g, 5b and 5q with Pim-1 ( o ) via H-bond formation and interactions with VAL126, LYS67, VAL52, GLY50, LEU44 via hydrophobic bond formation (Fig. 2). 
Bioavailability Study
Bioavailability is an important feature of potential drug, which determines how an investigated compound can penetrate a biological membrane. Thus, computational calculations for physiochemical analysis of molecules known as Lipinski's rule of five are used. For this purpose, all the compounds 5a-t were analyzed in silico to estimate their bioavailability via calculating parameters such as molecular weight (MW), partition coefficient (logP), the number of hydrogen bond donors (HBD) and hydrogen bond acceptors (HBA) and the topological polar surface area (TPSA). The obtained data showed that all compounds meet the criteria of Lipinski's rule. The molecular weight of the tested compounds ranged from 311 to 469 Da (<500 Da), and the log p values ranged from 3.547 to 4.826 (<5) except compound 5m (5.304), respectively. All derivatives have not more than five HBDs (-NH and -OH) and fewer than ten HBAs (N, O). The topological polar surface area (TPSA) is nothing but the surface of the polar atoms, which is contributing for correlation of passive molecular transport through membranes, therefore, allows the prediction of transport properties of drugs in GIT and BBB crossing [36] . From all these parameters, it can be observed that all title compounds exhibited a great %ABS ranging from 65 to 92% (Table 3) .
CONCLUSION
In conclusion, we synthesized a series of novel -cyano substituted 1,3-bisindolyl-2-propen-1-one derivatives and the structures were characterized by IR, 1 H NMR, 13 C NMR, and mass spectral data. All the newly synthesized compounds were in vitro evaluated for their anticancer activities against breast carcinoma (MCF-7). Among the compounds screened compounds 5g, 5b, and 5q exhibiting potent anticancer potential against breast carcinoma. Bioactivity of the methylsubstituted derivatives indicates positive influence of the electron releasing groups on anticancer potential. Molecular docking revealed significant interactions of active compounds in active site of Pim-1 kinase. All the compounds are in agreement with Lipinski parameters, which indicate the significant bioavailability of drugs. New anti-breast cancer agents are need of time, we believe that the new -cyano substituted 1,3-bisindolyl-2-propen-1-one derivatives reported in this work provide an interesting insight for further optimization. Further structural modifications of the identified hits are in progress in order to enhance the efficacy of these compounds.
ETHICS APPROVAL AND CONSENT TO PARTICI-PATE
Not applicable.
HUMAN AND ANIMAL RIGHTS
No Animals/Humans were used for studies that are the basis of this research.
CONSENT FOR PUBLICATION
CONFLICT OF INTEREST
The authors declare no conflict of interest, financial or otherwise.
